Furthermore, the analysis showed a statistically significant decrease in the expression levels of SNCA in patients with PD, by over fourfold; however, these results are not specific to PD, because a significant downregulation of this gene was also found in the neurological disease control group. This evidence concerns the gene SNCA and Parkinson disease.